Janux Therapeutics Inc Clinical Data Update Transcript
Good afternoon. My name is Jeannie, and I will be your conference operator today. I would like to welcome you to the Janux Therapeutics Clinical Data Update webcast. (Operator Instructions)
I would now like to turn the conference call over to Chad Rubin, Head of Investor Relations for Janux. You may begin your conference.
Thank you, Jeannie, and good afternoon, everyone. Today, Janux issued a press release announcing interim clinical data for the company's JANX007 clinical program. This press release, today's webcast and corresponding slides are available on our website.
Before we begin our prepared remarks, we would like to remind everyone that certain comments made by Janux management on this call will include forward-looking statements. These forward-looking statements are based on current information, assumptions and expectations that are subject to change and involve a number of risks and uncertainties that may cause actual results to differ materially from those contained in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
